ExodusPoint Capital Management »

Corvus Pharmaceuticals shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $634k 199k 3.18
2024-12-31 $72k 14k 5.33
2022-03-31 $42k 26k 1.64
2019-12-31 $124k 23k 5.42

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ameren Corporation (AEE)
Merck & Co Call Option (MRK)
Nebius Group Shs Class A Put Option (NBIS)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Procter & Gamble Company (PG)
Evergy (EVRG)
Microsoft Corporation Put Option (MSFT)

View all positions for ExodusPoint Capital Management

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
Point72 Asset Management
BlackRock
Vanguard Group
Adams Street Partners
Rtw Investments
Vivo Capital
Foresite Capital Management VI
Geode Capital Management
Perceptive Advisors
State Street Corporation
Morgan Stanley
Northern Trust
Goldman Sachs Group
Sphera Funds Management

View all funds holding Corvus Pharmaceuticals